EDGAR Filing Documents for 0001477932-17-004400

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001477932-17-004400

Filing Date

2017-09-11

Accepted

2017-09-08 20:23:02

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	ipix_10k.htm	10-K	1180773
2	AMENDED AND RESTATED BYLAWS	ipix_ex32.htm	EX-3.2	91683
3	OPINION OF GARY R. HENRIE, ESQ.	ipix_ex51.htm	EX-5.1	10517
4	COMMON STOCK PURCHASE AGREEMENT	ipix_ex106.htm	EX-10.6	142342
5	REGISTRATION RIGHTS AGREEMENT	ipix_ex107.htm	EX-10.7	60844
6	FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT	ipix_ex1016.htm	EX-10.16	28511
7	CONSENT	ipix_ex231.htm	EX-23.1	1233
8	CERTIFICATION	ipix_ex311.htm	EX-31.1	7961
9	CERTIFICATION	ipix_ex312.htm	EX-31.2	9870
10	CERTIFICATION	ipix_ex321.htm	EX-32.1	2928
11	CERTIFICATION	ipix_ex322.htm	EX-32.2	2987
	Complete submission text file	0001477932-17-004400.txt		6727778

Data Files

Seq	Description	Document	Type	Size
12	XBRL INSTANCE DOCUMENT	ipix-20170630.xml	EX-101.INS	1345804
13	XBRL TAXONOMY EXTENSION SCHEMA	ipix-20170630.xsd	EX-101.SCH	87006
14	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	ipix-20170630_cal.xml	EX-101.CAL	56649
15	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	ipix-20170630_def.xml	EX-101.DEF	276116
16	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ipix-20170630_lab.xml	EX-101.LAB	394571
17	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ipix-20170630_pre.xml	EX-101.PRE	366420

Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915

Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125

Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)